How does a vaccine get manufactured? How does it get to the patients who need it? The pressure to deliver a safe, effective vaccine is immense in the current COVID-19 climate. We need strong, reliable, and safe supply to meet patients’ needs.
This webinar will outline the complex journey of manufacturing a vaccine and explore the challenges in the cold chain logistics needed to deliver it.
François Meurice of GSK will examine the process of transforming raw materials into syringe-ready vaccines in the factory, including the time, quality criticality, and differences from a regular drug. Following this, leading global cold chain expert Toby Peters will look at distribution from factory door to patient, and the challenges inherent to keeping the vaccine at 2-8°C throughout - or at even lower temperatures as is the case with the Pfizer/BioNTech vaccine.
These sessions will encourage our engineers to better understand, amongst other things, the impacts of complex manufacturing, geographical location, scale of distribution as dependent on country government choices of vaccination programmes and data management to adequately track products in the supply chain.
Finally, François and Toby hosts a live Q&A session taking audience questions submitted during the webinar.
